SPERA PHARMA Inc. (SPERA MEDICAL)

Company Snapshot

Founded: 2017
Entity Type: Private
Employees: 249
Region: Japan
Headquarter: Osaka, Japan
Key Geographics: Asia-Pacific
Corporate Address: 17-85 Jusohonmachi 2-chome Yodogawa-ku Osaka 532-0024 Japan Tel. +81-6-7653-6818 www.spera-pharma.co.jp

Company Overview

Spera Medical develops a range of cardiac diagnostic tests using NGS and other technologies. Spera Medical offers whole-genome sequencing services through its Spera Genomics Division.

Spera Genomics offers a preventive whole-genome sequencing service. The patient’s DNA from blood samples is sequenced at a laboratory at McGill University’s Genome Quebec Innovation Center in Montreal. Genetic counseling is provided if a pathogenic variant is detected.

The main benefit of this preventive test is that it finds variants of which the patient may not be aware, including rare diseases, but that are clinically actionable. The initial focus of the test is the diagnosis of disease, and future expansions of the test may include pharmacogenomic, disease carrier status, nutrigenomics and/or ancestry information.

SPERA PHARMA Inc. (SPERA MEDICAL) In Reports

Rare Disease Diagnostics: Technologies and Global Markets

Explore the rare disease diagnostics, including the DNA sequencing industry, PCR industry, laboratory services industry, etc.

Global DNA Read, Write and Edit Market

The global market for DNA read, write and edit applications should grow from $17.0 billion in 2019 to $43.1 billion by 2024 with a compound annual growth rate of 20.5% during the period of 2019-2024.

Liquid Biopsy with Emphasis on Cancer: Global Markets to 2023

Get an overview of the global markets for liquid biopsy technologies, applications, industry subsegments along with analyses of global market trends with data from 2017, 2018 and projections of CAGRs through 2023 ...

Company's Business Segments

  • Pharmaceuticals Contract R&D and Manufacturing : The company provides one-stop services of CMC-related works from the early development stage through new drug applications.

Applications/End User Industries

  • Pharmaceutical
  • Life Sciences
AI Sentiment